Work

PB3569 Pharmacokinetics, Safety, and Efficacy of Different Doses of Pegylated Interferon Alpha-2b in Hydroxyurea-Resistant or Intolerant Essential Thrombocythemia: A Multicenter, Randomized, Open-Label Phase II Study

Year: 2026

Type: conference-abstract

Source: Research and Practice in Thrombosis and Haemostasis

DOI: 10.1016/j.rpth.2026.106188

Authors: Rongfeng Fu, HongYan Tong, Jian Huang, Minghui Duan, Tiejun Gong, Yong Wu, Na Xu, Wen Wu, Hu Zhou, Hongxia Shi, Ting Sun, Yalin Yin, Ruoyi He, Ying Zheng, Jianbo Gu, Lei Zhang

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,250

OpenAlex ID: W7220422271

Cites:

Cited by:

Related to: